M

Mirum Pharmaceuticals

ASBT inhibitors for rare liver diseases

Vice President, Global GMP Quality

Regulatory & Quality (Life Sciences)Confirmed live in the last 24 hours
Full-timeFoster City, CA, USA$320k - $340k

About the Job

Requirements

  • A bachelor's degree in biochemistry, chemistry, biology, or another science-related field is required.
  • At least 15 years of progressive Quality Assurance experience in pharmaceutical or biotechnology industries is required, including at least 10 years in a quality leadership role and/or people management with direct and indirect reports.
  • Extensive knowledge of current Good Manufacturing Practice (cGMP) manufacturing and Quality Management in compliance with FDA CBER and/or CDER and EMA requirements for globally regulated products is required.
  • Extensive knowledge of medical device development and commercialization in compliance with FDA 21 CFR 820, ISO 13485, and EMA MDR regulations is required.
  • Comprehensive knowledge of GMP, GDP, ISO, ICH, and global regulatory requirements is required.
  • Experience with the product lifecycle, including late-stage drug development, regulatory submissions such as NDA, MAA, and BLA, and commercial manufacturing is required.
  • Experience hosting inspections, preparing for inspection readiness, and recommending continuous improvements is required.
  • Ability to work cross-functionally and partner with internal and external stakeholders across multiple global regions is required.
  • Hands-on experience in product lifecycle management, including late-phase innovative drug development, medical devices, combination products, global commercial launches, and global CMC regulatory filings such as IND, IMPD, CTA, NDA, BLA, and MAA, is required.
  • Project and cross-functional team leadership and people-management skills across different cultures are required.
  • Thorough understanding and working experience in innovative drug development and manufacturing of drugs and biologics, including GMP operations, quality systems, ICH guidelines, FDA, EMA, and associated international regulatory requirements, are required.
  • Extensive working experience managing and overseeing analytical activities at CDMOs or CTLs with a quality mindset and leadership is required.
  • Strong analytical and problem-solving skills and strategic, technically driven decision-making ability are required.
  • Ability to influence and lead cross-functional teams is required.
  • A strong sense of ethics and honesty is required.
  • Ability to communicate with all levels of management and peers is required.
  • Effective written and verbal communication and interpersonal skills are required.

Responsibilities

  • Serve as GMP quality strategic leader to assist the head of quality in developing a compliant, collaborative, and phase-appropriate quality culture.
  • Develop and execute a global GMP quality strategy aligned with corporate goals and regulatory requirements.
  • Lead GMP QA and QC functional teams in the Quality group, fostering professional development and guiding staff in GMP/GDP competence to meet domestic and international regulatory requirements and guidelines, including FDA, EMA, MHRA, NMPA, and ICH.
  • Lead development and optimization of key processes, functional collaboration, transformational initiatives, and operational excellence through the GMP/GDP Quality Unit.
  • Provide strategic leadership, interactions, responses, CAPA plans, and implementation for audits and regulatory inspections.
  • Lead company GMP inspection readiness, including GMP quality improvement and maintenance.
  • Host and manage GMP PAI/PLI inspections at the company and support related CMO inspections.
  • Drive corporate values, vision, goals, and objectives through collaboration with senior leaders and cross-functional networks.
  • Serve as a GMP Quality advisor to cross-functional stakeholders across global organizations and subsidiaries.
  • Promote collaboration across internal and external teams and stakeholders to identify, design, and implement improvements across GMP and GDP quality responsibilities.
  • Establish, maintain, and ensure the effectiveness of GMP and GDP quality programs and documentation to assure GxP compliance in domestic and international regulatory environments.
  • Oversee, support, and perform GMP QA and QC activities and functions for drug manufacturing to ensure product quality and supply chain integrity.
  • Oversee and support clinical and commercial product release, including direct-to-market, partner, and distributor release.
  • Serve as the Material Review Board chairperson designee.
  • Develop and execute a global recall strategy integrating domestic and international recalls.
  • Serve as Recall Coordinator on the recall committee and support recall and mock-recall processes.
  • Collaborate with the Commercial Organization on launch strategies and NPP/EAP/CUP programs, providing input as a Quality subject matter expert.
  • Review and approve GMP, GDP, partner, and distributor quality/technical agreements.
  • Oversee timely review and approval of APQR generation.
  • Assess outcomes of GMP audits at CMOs, CTLs, and partners, and work with Technical Operations to drive improvements.
  • Provide strategic and managerial leadership related to company objectives, initiatives, and changing regulatory requirements; build, manage, and mentor high-performance QA and QC teams globally.
  • Oversee quality processes for product launch, manufacturing, and distribution.
  • Lead a culture of quality excellence, compliance, and continuous improvement across the organization.
  • Ensure the global GMP Quality Team meets stakeholder needs, focusing on efficiency, quality, budget management, and corporate growth.
  • Serve as Quality Head designee for other GxP areas as required.
  • Travel domestically and internationally at least 15%.

Desired Qualifications

  • An advanced degree is preferred.
  • Experience managing Product Quality Complaints and Pharmacovigilance Quality is a plus.
  • Experience in rare disease and/or biologics is a plus.

About the Company

Mirum Pharmaceuticals

ASBT inhibitors for rare liver diseases

Mirum develops therapies for rare liver diseases, led by LIVMARLI (maralixibat), an oral ASBT inhibitor that reduces bile acid buildup and itching in Alagille syndrome and other cholestatic conditions. It is pursuing LIVMARLI for additional rare diseases such as PFIC and biliary atresia and developing volixibat for primary sclerosing cholangitis and primary biliary cholangitis. The company combines drug development with commercialization in the United States and other major markets, working with physicians, payers, and patient groups to improve access. Its goal is to bring effective therapies to patients with rare liver diseases and build a sustainable commercial presence in key markets.

Company size
501-1,000
Company stage
IPO
Headquarters
Foster City, CA
Founded
2018

Recently Posted Jobs

Explore more opportunities at Mirum Pharmaceuticals

See more jobs